IFN-γ exposure in the tumor microenvironment enhances liver cancer stem cell stemness and sorafenib resistance by promoting mitochondrial PD-L1-mediated glycolytic reprogramming and ferroptosis inhibition via the Drp1-GPX4 pathway. The gene discussed is IFNG; the disease is neoplasm.